$8.61 Billion is the total value of Bellevue Group AG's 220 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 27.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
VRTX | Sell | VERTEX PHARMACEUTICALS INC | $386,302,000 | -1.8% | 1,480,253 | -17.4% | 4.49% | +10.6% |
IONS | Sell | IONIS PHARMACEUTICALS INC | $367,365,000 | +16.6% | 9,918,073 | -4.2% | 4.27% | +31.3% |
ARGX | Sell | ARGENX SEsponsored adr | $300,566,000 | -13.9% | 953,238 | -4.4% | 3.49% | -3.0% |
NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $283,448,000 | +4.6% | 3,023,451 | -4.9% | 3.29% | +17.9% |
MRNA | Sell | MODERNA INC | $282,395,000 | -34.9% | 1,639,349 | -4.1% | 3.28% | -26.7% |
INCY | Sell | INCYTE CORP | $226,141,000 | +4.2% | 2,847,400 | -3.7% | 2.63% | +17.4% |
ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $209,859,000 | +10.5% | 3,429,619 | -5.5% | 2.44% | +24.5% |
ANTM | Sell | ANTHEM INC | $202,205,000 | -4.2% | 411,637 | -9.6% | 2.35% | +8.0% |
ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $200,776,000 | -11.3% | 1,229,563 | -7.9% | 2.33% | -0.1% |
ABT | Sell | ABBOTT LABS | $192,090,000 | -21.8% | 1,622,927 | -7.0% | 2.23% | -11.9% |
UNH | Sell | UNITEDHEALTH GROUP INC | $155,898,000 | -0.6% | 305,701 | -2.1% | 1.81% | +12.0% |
ARVN | Sell | ARVINAS INC | $146,664,000 | -20.1% | 2,179,253 | -2.4% | 1.70% | -9.9% |
FATE | Sell | FATE THERAPEUTICS INC | $138,660,000 | -37.2% | 3,576,486 | -5.3% | 1.61% | -29.3% |
AGIO | Sell | AGIOS PHARMACEUTICALS INC | $120,204,000 | -15.9% | 4,129,292 | -5.1% | 1.40% | -5.3% |
DXCM | Sell | DEXCOM INC | $120,175,000 | -4.8% | 234,900 | -0.1% | 1.40% | +7.1% |
JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $117,528,000 | +4.0% | 754,981 | -14.9% | 1.36% | +17.2% |
RLAY | Sell | RELAY THERAPEUTICS INC | $117,295,000 | -7.0% | 3,918,962 | -4.6% | 1.36% | +4.8% |
EW | Sell | EDWARDS LIFESCIENCES CORP | $107,453,000 | -10.0% | 912,785 | -0.9% | 1.25% | +1.5% |
BDX | Sell | BECTON DICKINSON & CO | $105,444,000 | -7.9% | 396,405 | -13.0% | 1.22% | +3.6% |
DHR | Sell | DANAHER CORPORATION | $104,737,000 | -46.2% | 357,062 | -39.7% | 1.22% | -39.4% |
INSP | Sell | INSPIRE MED SYS INC | $102,036,000 | +5.4% | 397,506 | -5.5% | 1.18% | +18.7% |
SAGE | Sell | SAGE THERAPEUTICS INC | $101,034,000 | -26.4% | 3,052,404 | -5.4% | 1.17% | -17.1% |
MOH | Sell | MOLINA HEALTHCARE INC | $101,010,000 | +0.9% | 302,797 | -3.7% | 1.17% | +13.8% |
RVMD | Sell | REVOLUTION MEDICINES INC | $84,455,000 | -3.3% | 3,310,662 | -4.6% | 0.98% | +9.0% |
SWAV | Sell | SHOCKWAVE MED INC | $82,649,000 | +8.6% | 398,577 | -6.6% | 0.96% | +22.4% |
MYOV | Sell | MYOVANT SCIENCES LTD | $78,042,000 | -18.8% | 5,859,039 | -5.0% | 0.91% | -8.5% |
KZR | Sell | KEZAR LIFE SCIENCES INC | $77,585,000 | -5.6% | 4,668,148 | -5.1% | 0.90% | +6.2% |
MDT | Sell | MEDTRONIC PLC | $72,787,000 | +5.4% | 656,030 | -1.7% | 0.84% | +18.7% |
MGNX | Sell | MACROGENICS INC | $64,538,000 | -53.0% | 7,325,514 | -14.4% | 0.75% | -47.1% |
IDXX | Sell | IDEXX LABS INC | $64,449,000 | -17.0% | 117,810 | -0.1% | 0.75% | -6.6% |
HUM | Sell | HUMANA INC | $64,162,000 | -54.5% | 147,442 | -51.5% | 0.74% | -48.7% |
REGN | Sell | REGENERON PHARMACEUTICALS | $63,053,000 | +7.3% | 90,280 | -3.0% | 0.73% | +20.8% |
ALGN | Sell | ALIGN TECHNOLOGY INC | $61,629,000 | -36.0% | 141,351 | -3.6% | 0.72% | -27.9% |
EXEL | Sell | EXELIXIS INC | $61,640,000 | +17.9% | 2,719,000 | -4.9% | 0.72% | +32.8% |
CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $58,182,000 | -21.2% | 926,905 | -4.9% | 0.68% | -11.2% |
GMED | Sell | GLOBUS MED INCcl a | $54,985,000 | +0.5% | 745,254 | -1.6% | 0.64% | +13.1% |
BMY | Sell | BRISTOL-MYERS SQUIBB CO | $45,873,000 | -30.5% | 628,128 | -40.7% | 0.53% | -21.7% |
PEN | Sell | PENUMBRA INC | $43,016,000 | -22.7% | 193,654 | -0.0% | 0.50% | -13.1% |
TMO | Sell | THERMO FISHER SCIENTIFIC INC | $42,901,000 | -34.6% | 72,633 | -26.1% | 0.50% | -26.3% |
HALO | Sell | HALOZYME THERAPEUTICS INC | $40,845,000 | -4.8% | 1,024,200 | -4.1% | 0.47% | +7.2% |
IQV | Sell | IQVIA HLDGS INC | $36,790,000 | -20.3% | 159,120 | -2.7% | 0.43% | -10.3% |
HZNP | Sell | HORIZON THERAPEUTICS PUB L | $36,308,000 | -8.6% | 345,100 | -6.4% | 0.42% | +3.2% |
COO | Sell | COOPER COS INC | $34,750,000 | -0.4% | 83,216 | -0.1% | 0.40% | +12.2% |
TFX | Sell | TELEFLEX INCORPORATED | $34,672,000 | +8.0% | 97,714 | -0.1% | 0.40% | +21.8% |
ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $34,627,000 | +0.5% | 270,734 | -0.2% | 0.40% | +13.2% |
VEEV | Sell | VEEVA SYS INC | $34,121,000 | -19.0% | 160,601 | -2.6% | 0.40% | -8.8% |
BEAM | Sell | BEAM THERAPEUTICS INC | $33,396,000 | -31.6% | 582,821 | -4.9% | 0.39% | -22.9% |
SRRK | Sell | SCHOLAR ROCK HLDG CORP | $28,157,000 | -50.6% | 2,184,425 | -4.8% | 0.33% | -44.3% |
GBIO | Sell | GENERATION BIO CO | $27,027,000 | -1.4% | 3,682,180 | -4.9% | 0.31% | +11.0% |
HOLX | Sell | HOLOGIC INC | $21,186,000 | -52.2% | 275,783 | -52.4% | 0.25% | -46.2% |
RMD | Sell | RESMED INC | $20,940,000 | -7.1% | 86,349 | -0.2% | 0.24% | +4.7% |
ESPR | Sell | ESPERION THERAPEUTICS INC NE | $19,948,000 | -11.7% | 4,299,164 | -4.9% | 0.23% | -0.4% |
BNTX | Sell | BIONTECH SEsponsored ads | $19,063,000 | -34.8% | 111,766 | -1.5% | 0.22% | -26.8% |
MRSN | Sell | MERSANA THERAPEUTICS INC | $15,777,000 | -39.1% | 3,954,000 | -5.0% | 0.18% | -31.5% |
PHR | Sell | PHREESIA INC | $15,302,000 | -38.0% | 580,498 | -2.0% | 0.18% | -29.9% |
GH | Sell | GUARDANT HEALTH INC | $13,891,000 | -52.7% | 209,712 | -28.6% | 0.16% | -46.9% |
AMGN | Sell | AMGEN INC | $13,010,000 | -0.6% | 53,800 | -7.5% | 0.15% | +11.9% |
HCAT | Sell | HEALTH CATALYST INC | $11,095,000 | -59.6% | 424,611 | -38.7% | 0.13% | -54.4% |
BDTX | Sell | BLACK DIAMOND THERAPEUTICS I | $9,122,000 | -50.6% | 3,293,000 | -4.9% | 0.11% | -44.2% |
WVE | Sell | WAVE LIFE SCIENCES LTD | $9,126,000 | -36.9% | 4,562,858 | -0.9% | 0.11% | -28.9% |
AMWL | Sell | AMERICAN WELL CORPcl a | $7,450,000 | -42.0% | 1,769,703 | -16.8% | 0.09% | -34.1% |
FIXX | Sell | HOMOLOGY MEDICINES INC | $5,007,000 | -20.8% | 1,647,122 | -5.2% | 0.06% | -10.8% |
GILD | Sell | GILEAD SCIENCES INC | $4,961,000 | -56.5% | 83,450 | -46.8% | 0.06% | -50.8% |
BIIB | Sell | BIOGEN INC | $4,707,000 | -96.3% | 22,350 | -95.7% | 0.06% | -95.8% |
BNR | Sell | BURNING ROCK BIOTECH LTDsponsored ads | $4,077,000 | -12.7% | 438,869 | -10.4% | 0.05% | -2.1% |
PFE | Sell | PFIZER INC | $2,407,000 | -63.9% | 46,500 | -58.8% | 0.03% | -59.4% |
BCYC | Sell | BICYCLE THERAPEUTICS PLCsponsored ads | $1,602,000 | -51.0% | 36,500 | -32.0% | 0.02% | -44.1% |
GTH | Sell | GENETRON HLDGS LTDads | $1,173,000 | -73.4% | 535,822 | -25.9% | 0.01% | -68.9% |
MRTX | Sell | MIRATI THERAPEUTICS INC | $1,217,000 | -61.6% | 14,800 | -31.5% | 0.01% | -57.6% |
NTLA | Sell | INTELLIA THERAPEUTICS INC | $1,184,000 | -39.7% | 16,294 | -1.8% | 0.01% | -30.0% |
XNCR | Sell | XENCOR INC | $1,110,000 | -46.9% | 41,600 | -20.2% | 0.01% | -40.9% |
ARCT | Sell | ARCTURUS THERAPEUTICS HLDGS | $1,103,000 | -28.4% | 40,900 | -1.7% | 0.01% | -18.8% |
INBX | Sell | INHIBRX INC | $1,107,000 | -49.8% | 49,700 | -1.6% | 0.01% | -43.5% |
LH | Sell | LABORATORY CORP AMER HLDGS | $1,121,000 | -57.8% | 4,250 | -49.7% | 0.01% | -51.9% |
QTRX | Sell | QUANTERIX CORP | $1,042,000 | -93.8% | 35,704 | -91.0% | 0.01% | -93.1% |
KRYS | Sell | KRYSTAL BIOTECH INC | $918,000 | -6.2% | 13,800 | -1.4% | 0.01% | +10.0% |
MCK | Sell | MCKESSON CORP | $696,000 | +18.8% | 2,274 | -3.6% | 0.01% | +33.3% |
IDYA | Sell | IDEAYA BIOSCIENCES INC | $517,000 | -53.5% | 46,200 | -1.7% | 0.01% | -45.5% |
OPT | Sell | OPTHEA LTDsponsored ads | $313,000 | -14.9% | 48,000 | -2.0% | 0.00% | 0.0% |
DLB | Sell | DOLBY LABORATORIES INC | $125,000 | -63.6% | 1,600 | -55.6% | 0.00% | -75.0% |
STNE | Exit | STONECO LTD | $0 | – | -4,300 | -100.0% | -0.00% | – |
CLX | Exit | CLOROX CO DEL | $0 | – | -1,200 | -100.0% | -0.00% | – |
OLED | Exit | UNIVERSAL DISPLAY CORP | $0 | – | -1,365 | -100.0% | -0.00% | – |
A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -1,000 | -100.0% | -0.00% | – |
JD | Exit | JD.COM INCspon adr cl a | $0 | – | -3,600 | -100.0% | -0.00% | – |
AZPN | Exit | ASPEN TECHNOLOGY INC | $0 | – | -1,874 | -100.0% | -0.00% | – |
SPOT | Exit | SPOTIFY TECHNOLOGY SA | $0 | – | -1,100 | -100.0% | -0.00% | – |
FTNT | Exit | FORTINET INC | $0 | – | -803 | -100.0% | -0.00% | – |
EA | Exit | ELECTRONIC ARTS INC | $0 | – | -2,270 | -100.0% | -0.00% | – |
AXP | Exit | AMERICAN EXPRESS CO | $0 | – | -1,500 | -100.0% | -0.00% | – |
GGG | Exit | GRACO INC | $0 | – | -4,500 | -100.0% | -0.00% | – |
MKL | Exit | MARKEL CORP | $0 | – | -300 | -100.0% | -0.00% | – |
ENTG | Exit | ENTEGRIS INC | $0 | – | -3,000 | -100.0% | -0.00% | – |
CYBR | Exit | CYBERARK SOFTWARE LTD | $0 | – | -2,100 | -100.0% | -0.00% | – |
NYT | Exit | NEW YORK TIMES COcl a | $0 | – | -7,500 | -100.0% | -0.00% | – |
LYV | Exit | LIVE NATION ENTERTAINMENT IN | $0 | – | -4,700 | -100.0% | -0.01% | – |
CLLS | Exit | CELLECTIS S Aspon ads | $0 | – | -82,500 | -100.0% | -0.01% | – |
NVAX | Exit | NOVAVAX INC | $0 | – | -10,400 | -100.0% | -0.02% | – |
ZTS | Exit | ZOETIS INCcl a | $0 | – | -7,100 | -100.0% | -0.02% | – |
LLY | Exit | LILLY ELI & CO | $0 | – | -7,552 | -100.0% | -0.02% | – |
SYNH | Exit | SYNEOS HEALTH INCcl a | $0 | – | -21,500 | -100.0% | -0.02% | – |
DGX | Exit | QUEST DIAGNOSTICS INC | $0 | – | -15,250 | -100.0% | -0.03% | – |
CTLT | Exit | CATALENT INC | $0 | – | -23,100 | -100.0% | -0.03% | – |
OSCR | Exit | OSCAR HEALTH INCcl a | $0 | – | -679,952 | -100.0% | -0.06% | – |
BGNE | Exit | BEIGENE LTDsponsored adr | $0 | – | -23,000 | -100.0% | -0.06% | – |
IMAB | Exit | I MABsponsored ads | $0 | – | -144,957 | -100.0% | -0.07% | – |
ZLAB | Exit | ZAI LAB LTDadr | $0 | – | -126,600 | -100.0% | -0.08% | – |
NEO | Exit | NEOGENOMICS INC | $0 | – | -469,695 | -100.0% | -0.16% | – |
MASI | Exit | MASIMO CORP | $0 | – | -131,376 | -100.0% | -0.40% | – |
VCRA | Exit | VOCERA COMMUNICATONS INC | $0 | – | -1,160,613 | -100.0% | -0.78% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- BB Biotech AG #1
- Bellevue Asset Management AG #2
- Bellevue Asset Management (UK) Ltd. #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
Incyte Corporation | 31 | Q3 2023 | 5.4% |
INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
ABBOTT LABS | 31 | Q3 2023 | 4.6% |
ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
SC 13G | 2023-02-14 |
SC 13G | 2023-02-14 |
13F-HR | 2022-11-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.